Patient: Page 12
-
Drew Angerer via Getty Images
3 ways pharma can prep for Biden’s sweeping drug pricing policies
Now that Medicare will be able to negotiate drug prices under the Inflation Reduction Act, the industry can expect to see some changes. Here are some tips on how to navigate the changing tide.
By Karissa Waddick • Aug. 18, 2022 -
Permission granted by George Magrath.
The CEO in the ophthalmologist’s coat
In balancing two roles — Lexitas CEO and practicing physician — George Magrath brings a patient-first perspective to developing and advancing eye treatments.
By Alexandra Pecci • Aug. 16, 2022 -
Explore the Trendline➔
Stock via Getty Images
TrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
Evgenyi_Eg via Getty Images
Right under our noses: Could COVID-19 vaccines be better as nasal spray?
Nasal vaccines under development by Codagenix, Xanadu Bio and others have the potential to finally help reduce virus transmission and breakthrough infections.
By Kelly Bilodeau • Aug. 16, 2022 -
Win McNamee/Staff via Getty Images
Despite AbbVie’s Botox prowess, underdog Galderma has leveraged soft skills to succeed in aesthetics
Galderma may not have the biggest name in aesthetics, but as the sector grows past pandemic lows, the company is relying on its people to build a loyal customer base.
By Michael Gibney • Aug. 11, 2022 -
Stock via Getty Images
4 ways to nail the launch of your cell therapy
A consultant’s view on how pharma companies should approach patient experience challenges when rolling out an autologous cell therapy.
By Meagan Parrish • Aug. 10, 2022 -
Mario Tama via Getty Images
The ‘alarming’ spread of Monkeypox — by the numbers
With vaccine and treatment supplies constrained, the virus is becoming ‘less predictable.’
By Meagan Parrish • Aug. 8, 2022 -
MJ_Prototype via Getty Images
Generic subscription services like Mark Cuban’s promise cheaper drugs — but will it work?
Companies like Cost Plus Drugs and DiRx can bring generics directly to consumers at a fraction of the price, but whether it’s enough to fix the inflated U.S. healthcare system is yet to be seen.
By Michael Gibney • Aug. 4, 2022 -
Lisa Maree Williams via Getty Images
Q&ALupus discovery lends clues to the fight against long COVID
So far, pharma has yet to provide an answer for long COVID. But award-winning lupus research by Yale professor Akiko Iwasaki could help lead the way.
By Kelly Bilodeau • July 27, 2022 -
iStock via Getty Images
Democrats think they've found a balance between drug innovation and pricing negotiation
A look at Congress’ push to pass drug pricing reform and why the latest attempt could actually succeed.
By Karissa Waddick • July 26, 2022 -
Chris Hondros / Staff via Getty Images
Q&ABehind Pfizer's new quest to target a 'transformation' in pharma
A combined venture with Roivant — called Priovant Therapeutics — is looking to be a forerunner in the burgeoning autoimmune disease market.
By Kelly Bilodeau • July 25, 2022 -
Stock via Getty Images
The earlier the better: New consortium leverages infant screening to accelerate treatment
Inozyme Pharma has joined a genomic sequencing program developing a novel rapid test for 388 genetic diseases.
By Kim Ribbink • July 25, 2022 -
Maddie Meyer / Staff via Getty Images
Moderna's next vax target? A little-known cause of birth defects
How the mRNA-based biotech is developing the first-ever prophylactic for a devastating virus.
By Karissa Waddick • July 21, 2022 -
Permission granted by John LaMattina
Pfizer's former R&D head takes on drug pricing misconceptions in new book
John LaMattina has something to say about the industry — and he hopes patients are listening.
By Meagan Parrish • July 19, 2022 -
NanoStockk/istockphoto.com
Sponsored by OPEN HealthHow digital health is changing the relationship between patients and health providers
The pandemic has forced the pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes
July 18, 2022 -
FG Trade via Getty Images
ProfileThe power of the underdog: A rare disease nonprofit working to help patients win against the odds
Elizabeth Izard Apelles is finding innovative ways to champion rare disease patients through an emerging platform from Honeycomb Health.
By Alexandra Pecci • July 13, 2022 -
iStock via Getty Images
Pharma companies take a fresh approach to inclusion in new DTC ads
AstraZeneca and Amgen are emphasizing diversity and authenticity in campaigns for lupus and severe asthma therapies.
By Karissa Waddick • July 5, 2022 -
Stock via Getty Images
The oncology market is surging despite a decline in routine screenings
A new report from IQVIA reveals the current challenges — and promise — in cancer drug R&D.
By Kelly Bilodeau • June 28, 2022 -
iStock via Getty Images
With abortion access restricted across the U.S., a new diagnostic aims to eliminate birth control's pain points
The hormonal and genetic test developed by Adyn is designed to predict and prevent adverse birth control side effects.
By Karissa Waddick • June 28, 2022 -
Permission granted by Dan Vahdat.
Q&A'Nobel Prize of pharma' helps put Huma's digital health platform on the global map
The company’s CEO explains how its Prix Galien award-winning app bridges patient care, treatment support and clinical research.
By Kim Ribbink • June 23, 2022 -
Karissa Waddick/PharmaVoice
#DIA2022: Building 'guardrails' in the FDA's accelerated approval program
Regulatory experts weigh in on ways to enhance the controversial drug approval approach.
By Karissa Waddick • June 21, 2022 -
Valiantsin Suprunovich via Getty Images
The public health sleuth
In her decades-long career, Mary Pittman, CEO of the Public Health Institute, has seen — and helped solve — one public health mystery after another.
By Alexandra Pecci • June 21, 2022 -
Stock via Getty Images
Q&A // Biotech SpotlightBiotech spotlight: Karuna Therapeutics’ mission to rejuvenate the field of neuroscience
An effective treatment for psychiatric disorders such as schizophrenia might require a holistic approach to avoid serious side effects, says CEO Steve Paul.
By Kim Ribbink • June 16, 2022 -
ChiccoDodiFC via Getty Images
A patient-funded ALS drug offers hope where few treatments exist
Eledon Pharmaceuticals’ grassroots-backed drug recently entered clinical trials.
By Kelly Bilodeau • June 15, 2022 -
Stock via Getty Images
Q&AA combo of precision meds and diagnostics could disrupt mental healthcare
HMNC Brain Health, a clinical-stage company, is leveraging cutting-edge tech to offer a new approach to mental health challenges.
By Kelly Bilodeau • June 8, 2022 -
Stock via Getty Images
ProfileAfter losing her daughter to a rare disease, Sharon King is looking to rewrite the playbook of drug development
The communications pro is lending her community-building, storytelling expertise to the Bespoke Gene Therapy Consortium.
By Alexandra Pecci • June 7, 2022
Previous
